Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology
Ketamine is a general anesthetic that is used also as an anti-depressant, but its use is associated with cystitis. Here, the authors show that ketamine is an antagonist of the Cav1.2 channel in bladder smooth muscle cells, that ablation of this channel in mice mimics the cystitis induced by ketamine...
Saved in:
| Main Authors: | Huan Chen, David H. Vandorpe, Xiang Xie, Seth L. Alper, Mark L. Zeidel, Weiqun Yu |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/4c6049dad79c426db90368daaeea5f52 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Allicin disrupts cardiac Cav1.2 channels via trafficking
by: Dan Han, et al.
Published: (2019) -
The interactive effects of ketamine and magnesium upon depressive-like pathology
by: Razmjou S, et al.
Published: (2016) -
Function of cone and cone-related pathways in CaV1.4 IT mice
by: Lucia Zanetti, et al.
Published: (2021) -
Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice
by: Wei Xu, et al.
Published: (2020) -
Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study
by: Agata Korlatowicz, et al.
Published: (2021)